Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.4.3. The previous Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-12T14:48:45.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Fallopian tube cancer is now listed as a condition and the Genetic and Rare Diseases Information Center resource is added; the page version updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-11T23:47:05.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-04T22:58:47.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels, including the 'Last Update Submitted that Met QC Criteria' entry, 'No FEAR Act Data' capitalization, and the revision/version to v3.4.0. These are minor UI/metadata updates and do not affect the study content or results; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T21:46:44.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the study page; no substantive content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:46:13.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The Locations section was expanded with new sites across the US, Canada, Europe, Australia, and other regions, while many of the previous locations were removed.
    Difference
    3%
    Check dated 2025-12-23T22:05:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.